Miltenyi Biotec, a German company, has entered the Indian market by opening its first office in India and establishing a Centre of Excellence (CoE). The company aims to support biomedical discovery and advanced cellular therapy. The CoE will be the first of its kind in India, offering training on cell and gene therapy approaches from proof of concept through commercialization.
The announcement was made after a meeting between Chief Minister Revanth Reddy and Boris Stoffel, Managing Director of Miltenyi Biotec. The CoE will provide easier access to manufacturing solutions, research, and expertise for scientists, clinicians, and researchers in India. Telangana CM Revath Reddy welcomed the company to the state, highlighting the importance of advancing novel therapies and providing healthcare options for patients in India and globally.
Miltenyi Biotec is focused on providing training in cell and gene therapy in Hyderabad to address significant unmet medical needs. The company’s goal is to drive accessibility, affordability, and availability of these therapies through local development and manufacturing in India.
